About Sagres Discovery
Sagres Discovery is a company based in Davis (United States) founded in 2000 by David Ferrick. It operates as a B2B. Sagres Discovery has raised $20 million across 1 funding round from investors including CDIB Capital Group, Burrill and Company and Forward Ventures. Sagres Discovery operates in a competitive market with competitors including Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Champion Oncology, among others.
- Headquarter Davis, United States
- Founders David Ferrick
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$20 M (USD)
in 1 rounds
-
Latest Funding Round
$20 M (USD), Series A
Oct 03, 2001
-
Investors
CDIB Capital Group
& 6 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Sagres Discovery
Sagres Discovery has successfully raised a total of $20M through 1 strategic funding round. The most recent funding activity was a Series A round of $20 million completed in October 2001. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Sagres Discovery
Sagres Discovery has secured backing from 7 investors, including venture fund and institutional investors. Prominent investors backing the company include CDIB Capital Group, Burrill and Company and Forward Ventures.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Life Sciences focused VC firm that does early stage investments in the US
|
Locked | Locked | Locked | |
|
-
|
Locked | Locked | Locked | |
|
Investments are made in innovative life science companies globally.
|
Locked | Locked | Locked |
Investor details for Sagres Discovery
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Sagres Discovery
Investment portfolio details for Sagres Discovery
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Sagres Discovery
Detailed financials for Sagres Discovery
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Sagres Discovery Comparisons
Peer comparison for Sagres Discovery
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Sagres Discovery
Sagres Discovery operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Biocytogen, Interius Biotherapeutics, Applied StemCell, GenOway and Champion Oncology, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Integrated solutions for next-generation antibody drug development are provided.
|
|
| Locked | Locked | Locked |
Developer of gene therapies for treating multiple diseases
|
|
| Locked | Locked | Locked |
Provider of animal and cell line models as tools for drug discovery and diagnostics
|
|
| Locked | Locked | Locked |
Provider of transgenic rodent models and customized cell lines for preclinical development
|
|
| Locked | Locked | Locked |
Drug response assays are performed using murine in vivo models.
|
|
| Locked | Locked | Locked |
Provides 3D tumor models and assays for cancer research and preclinical testing services.
|
Detailed competitors of Sagres Discovery
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Sagres Discovery
Complete news archive for Sagres Discovery
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sagres Discovery
Sagres Discovery was founded in 2000 and raised its 1st funding round 1 year after it was founded.
Sagres Discovery is headquartered in Davis, United States. It is registered at Davis, California, United States.
David Ferrick is the current CEO of Sagres Discovery. They have also founded this company.
Sagres Discovery is a funded company, having raised a total of $20M across 1 funding round to date.
Sagres Discovery creates innovative mouse models to analyze genes causing cancer diseases through providing healthcare solutions, advancing biotech innovations, research and development, and cancer genetics. Prioritizing client-centric approaches, it ensures high-quality outcomes, innovation, and sustainable practices in its field. It continues to evolve, meeting industry challenges with strategic approaches.
Sagres Discovery's top competitors include Biocytogen, Applied StemCell and GenOway.
Sagres Discovery has 7 investors. Key investors include CDIB Capital Group, Burrill and Company, Forward Ventures, Axiom Venture Partners, and Novartis Venture Fund.